News | May 30, 2024
Merck inks MoU with KAIST to advance scientific collaboration
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas
Back-to-back plenary presentations for LAURA and ADRIATIC Phase III trials reinforce the potential of Tagrisso and Imfinzi in early lung cancer settings
Theophylline is used to treat asthma and chronic obstructive pulmonary disease
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Establishing Asymchem’s first manufacturing footprint in Europe
Launch of 20 new medicines expected by 2030
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
The collaboration aims to bolster healthcare entrepreneurship
Subscribe To Our Newsletter & Stay Updated
